Opposite motor responses elicited by ethanol in the posterior VTA: The role of acetaldehyde and the non-metabolized fraction of ethanol


Por: Marti-Prats, L, Sanchez-Catalan, M, Orrico, A, Zornoza, T, Polache, A and Granero, L

Publicada: 1 sep 2013
Resumen:
Recent electrophysiological evidence suggests that ethanol simultaneously exerts opposite effects on the activity of dopamine (DA) neurons in the ventral tegmental area (VTA) through two parallel mechanisms, one promoting and the other reducing the GABA release onto VTA DA neurons. Here we explore the possible behavioural implications of these findings by investigating the role displayed by acetaldehyde (the main metabolite of ethanol) and the non-metabolized fraction of ethanol in motor activity of rats. We analyse the appearance of motor activation or depression after intra-VTA administration of ethanol in rats subjected to different pharmacological pre-treatments designed to preferentially test either the effects of acetaldehyde or the non-metabolized ethanol. Motor activity was evaluated after intra-VTA administration of 35 nmol of ethanol, an apparently ineffective dose that does not modify the motor activity of animals. Pharmacological pre-treatments were used in order to either increase (cyanamide, 10 mg/kg, ip) or decrease (D-penicillamine, 50 mg/kg, ip and sodium azide, 7 mg/kg, ip) acetaldehyde levels in the VTA. Pre-treatments aimed to augment acetaldehyde, increased motor activity of rats. Otherwise, pre-treatments intended to decrease local acetaldehyde levels evoked significant reductions in motor activity that were prevented by the local blockade (bicuculline, 17.5 pmol) of the GABA(A) receptors. Our findings suggest that the brain-generated acetaldehyde is involved in the stimulant effects of ethanol, whereas the non-biotransformed fraction of ethanol, acting through the GABA(A) receptors, would account for the depressant effects. The present behavioural findings suggest that ethanol dually modulates the activity of DA neurons. (C) 2013 Elsevier Ltd. All rights reserved.

Filiaciones:
Marti-Prats, L:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain

Sanchez-Catalan, M:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain

:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain

Zornoza, T:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain

Polache, A:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain

Granero, L:
 Univ Valencia, Fac Farm, Dept Farm & Tecnol Farmaceut, E-46100 Burjassot, Spain
ISSN: 00283908





Neuropharmacology
Editorial
Elsevier Ltd., THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 72 Número:
Páginas: 204-214
WOS Id: 000321941800023
ID de PubMed: 23643753

MÉTRICAS